Biogen Inc (BIIB) Shares Fall 8.2% -- What GF Score of 74 Tells Investors

Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.

This could be a key move for future growth.

Biogen (BIIB) Stock Jumps on Analyst Upgrade Before Key Alzheimer’s Data Release

Truist upgrades Biogen (BIIB) stock to Buy with $235 target ahead of Alzheimer's drug data. Shares rise 1.3% premarket on positive analyst o

Biogen's Q2 2026 Earnings: What to Expect